Celltrion’s monoclonal antibody treatment for COVID-19 regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19[…]
Read more